Key Finding
Acupuncture used alongside ovulation induction agents was associated with improved clinical pregnancy rates (OR 1.99–4.83) and significant reductions in glycaemic markers in women with PCOS.
Polycystic ovary syndrome (PCOS) affects millions of women worldwide, contributing to difficulty getting pregnant, blood sugar problems, and hormonal imbalances. Researchers wanted to understand how non-drug treatments — including lifestyle changes, nutritional supplements, and therapies like acupuncture — might help manage these challenges. To find answers, they reviewed 12 high-quality scientific summaries covering hundreds of randomized trials and thousands of women with PCOS.
The results were encouraging across several areas. Women who made lifestyle changes — including improving their diet and increasing physical activity — saw benefits in blood sugar control, hormonal symptoms like excess hair growth, and body weight. Supplements like inositol and N-acetylcysteine showed early promise in helping women achieve clinical pregnancy. Acupuncture also stood out: when added alongside conventional ovulation-stimulating treatments, it showed meaningful improvements in pregnancy rates and blood sugar regulation. Specifically, acupuncture was associated with notable reductions in fasting blood insulin levels, which is particularly relevant for women with PCOS who often struggle with insulin resistance.
It is important to note that the overall quality of evidence was rated as low or very low, meaning larger, well-designed studies are still needed before firm conclusions can be drawn. Researchers emphasize that more robust trials are required to confirm these findings and determine which treatments work best for which women.
What this means for you: if you have PCOS, non-pharmacological approaches — including acupuncture — may offer meaningful support alongside conventional care, particularly for blood sugar management and fertility outcomes. These treatments appear safe and show real potential, even if the science is still catching up.
If you are considering acupuncture for PCOS, seek out a licensed, qualified acupuncture practitioner with experience in women's hormonal health.
This umbrella review synthesized 12 high-quality systematic reviews (AMSTAR scores 8–11) evaluating non-pharmacological interventions in women with PCOS, encompassing up to 27 RCTs and 2,093 participants across lifestyle, nutraceutical, and alternative medicine modalities. Acupuncture, assessed as an adjunct to ovulation induction agents, demonstrated clinically relevant improvements in clinical pregnancy rates (OR 1.99–4.83) and glycaemic outcomes, including fasting blood insulin and HOMA-IR (MD: −1.90 to −3.43). Lifestyle interventions improved hirsutism (Ferriman-Gallwey MD: −1.01 to −1.19), glycaemic markers, and BMI. Inositol and N-acetylcysteine showed preliminary fertility benefits. All significant outcomes were graded low or very low quality per GRADE criteria, limiting definitive clinical recommendations. Key clinical takeaway: acupuncture as an adjunctive therapy shows measurable benefit for insulin resistance and fertility outcomes in PCOS, warranting inclusion in integrative treatment discussions while larger, adequately powered primary RCTs are pursued.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 A systematic review of 214 studies found that acupuncture and moxibustion improve endometrial receptivity in IVF-ET patients by enhancing uterine lining thickness, blood flow, and hormone levels through multiple molecular mechanisms including VEGF-mediated angiogenesis and AMPK/mTOR autophagy pathways.
📌 Live birth rate — the outcome most important to patients undergoing acupuncture-assisted IVF — remains one of the least-supported measures in existing clinical trial evidence, highlighting a critical gap between research priorities and patient concerns.
📌 Acupoint application therapy significantly increased high-quality embryo rates to 47% in ovarian endometriosis IVF patients compared to 31% in the placebo group, while normalizing dysregulated follicular steroid hormone levels linked to impaired oocyte yield.